Patient-specific induced pluripotent stem cells (iPSCs) are a powerful tool to investigate the molecular mechanisms underlying Parkinson’s disease (PD), and might provide novel platforms for systematic drug screening. Several strategies have been developed to generate iPSC-derived tyrosine hydroxylase (TH)-positive dopaminergic neurons (DAn), the clinically relevant cell type in PD; however, they often result in mixed neuronal cultures containing only a small proportion of TH-positive DAn. To overcome this limitation, we used CRISPR/Cas9-based editing to generate a human iPSC line expressing a fluorescent protein (mOrange) knocked-in at the last exon of the TH locus. After differentiation of the TH-mOrange reporter iPSC line, we confirmed that mOrange expression faithfully mimicked endogenous TH expression in iPSC-derived DAn. We also employed calcium imaging techniques to determine the intrinsic functional differences between dopaminergic and non-dopaminergic ventral midbrain neurons. Crucially, the brightness of mOrange allowed direct visualization of TH-expressing cells in heterogeneous cultures, and enabled us to isolate live mOrange-positive cells through fluorescence-activated cell sorting, for further differentiation. This technique, coupled to refined imaging and data processing tools, could advance the investigation of PD pathogenesis and might offer a platform to test potential new therapeutics for PD and other neurodegenerative diseases.
Parkinson’s disease (PD) is an incurable neurodegenerative disorder in the elderly that is characterized by the progressive loss of dopaminergic neurons (DAn) in the substantia nigra pars compacta1. Its incidence in Western countries is rising due to the progressive aging of the population, imposing a major burden on national healthcare systems. Despite decades of intense research, the pathogenic mechanisms of PD remain unclear owing to the lack of experimental models that recapitulate the main features of the disease. The development of induced pluripotent stem cell (iPSC) technology has opened new horizons for modeling PD, as iPSCs can be generated from patients’ somatic cells and differentiated into disease-relevant cell types, which would capture the genetic complexity of PD. Furthermore, human iPSC-derived neuronal models offer unprecedented access to the early stages of the disease, allowing the investigation of the events that initiate the pathologic process in PD2,3.
The development of hiPSC-based strategies to treat or model PD, however, is hampered by the lack of efficient protocols for the directed differentiation of stem cells into DAn with the appropriate characteristics of A9-subtype ventral midbrain neurons – the neuronal cell type lost in PD (for review, see4). Indeed, although several protocols have been developed to differentiate stem cells into functional DAn5,6,7,8, the differentiated progeny are a heterogeneous mix of DA and non-DA cells, which impedes identifying live DAn. Moreover, the wide variability in terms of differentiation ability among different iPSC lines represents a further limitation in the field, which hinders data interpretation9,10,11.
Several strategies have evolved in recent years to overcome these issues, based mainly on the use of DAn lineage reporters and, in particular, the expression of tyrosine hydroxylase (TH) – the first and rate-limiting step in the synthesis of dopamine – as a marker for identifying DAn12. However, classical approaches relying on the expression of a reporter construct controlled by the proximal promoter of the gene of interest have been unsatisfactory13,14. New gene-editing strategies have been more successful, enabling the insertion of reporter genes under the control of endogenous regulatory sequences. In this regard, two recent studies showed that the insertion of reporter constructs into the TH gene locus faithfully mimics endogenous TH expression during in vitro and in vivo differentiation15,16. But neither of these reporter lines allowed for the direct visualization of TH-positive (TH+) neurons in living cells, likely due to the low absolute expression of TH even in DAn.
In the present work, we used a CRISPR/Cas9-based editing strategy to generate a human iPSC line carrying the fluorescent protein mOrange knocked-in at the last exon of TH. We first confirmed the exact colocalization of mOrange expression from the reporter gene with endogenous TH expression in TH-mOrange hiPSC differentiated into DAn. We then used flow cytometry to evaluate mOrange reporter expression, which could be detected as early as 25 days in vitro. Calcium imaging experiments revealed electrophysiological differences between ventral midbrain dopaminergic neurons and non-dopaminergic neurons. This approach also enabled us to isolate pure and viable DAn cell populations from heterogeneous cultures. We thus provide a novel cellular model to study PD phenotypes in vitro, which may be useful for the implementation of high throughput biological discovery applications including drug target identification.
CRISPR/Cas9-mediated knock-in of a P2A-mOrange cassette in-frame with TH gene
With the aim of identifying TH+ neurons among living cells, we generated a genetic reporter construct that could robustly and faithfully label DAn. We used CRISPR/Cas9 genome-editing to knock-in a P2A-mOrange fluorescent construct adjacent to the last exon of the TH gene. We chose mOrange because it is one of the brightest monomeric fluorescent proteins available17. The designed CRISPR/Cas9 guide RNA spacer sequence overlapped the TH stop codon, thereby preventing retargeting of properly edited alleles. The hiPSC line SP_112, generated from a healthy control, was co-transfected with the homology-directed repair (HDR) and CRISPR/Cas9 plasmids (Fig. 1A). The HDR plasmid contained a LoxP-flanked pRex1-NeoR cassette, allowing selection of recombination events. Resistant clones were molecularly characterized and the selection cassette excised (Figs 1B,C and S1). This editing approach induced >50% of biallelic integration of the exogenous sequences (data not shown). The edited hiPSC line was then expanded and characterized for the expression of pluripotency markers including OCT4, SOX2, NANOG, SSEA4, SSEA3 and TRA-1-81, and also karyotype integrity (Fig. 1D,E).
mOrange expression faithfully recapitulates endogenous TH expression in ventral midbrain dopaminergic neurons
To differentiate the edited iPSC line towards ventral midbrain DAn (vmDAn), we followed a previously published midbrain floor plate differentiation protocol6 (see Methods for details) (Fig. 2A,B). Under these conditions, some fluorescent mOrange-positive cells could be observed as early as 25 days of differentiation, and the number and the fluorescence intensity of the cells increased over time. At day 50 of differentiation, cells were live-imaged (Fig. 2C) and fixed to confirm the fidelity of the reporter. Immunofluorescence analysis of fluorescent neurons revealed an absolute correlation between the mOrange signal and TH- and mRFP1-immunoreactivity (mOrange is an mRFP1 derivative) (Fig. 2D). By contrast, MAP2-positive neurons that were negative for TH immunoreactivity were also negative for mOrange (Fig. 2D), confirming the specificity of the transgene in replicating the endogenous TH expression pattern.
Further analysis at day 50 of differentiation demonstrated that ~30% of TH/mOrange-positive cells expressed the ventral midbrain forkhead box protein A2 (FOXA2) and, more importantly, the same proportion of cells also expressed the A9 domain-specific marker G protein-activated inward rectifier potassium channel 2 (GIRK2) (Fig. 2E,G). No differences between TH-mOrange edited and non-edited parental SP_11 iPSC lines were observed regarding the expression of vmDAn markers upon differentiation (Fig. 2F,G), indicating that differentiation was not perturbed by the insertion of the transgene.
Overall, our results show that the generated TH-mOrange iPSC line faithfully reports endogenous TH expression and that the genetic modification does not impair mDA specification.
Ventral midbrain dopaminergic neurons have electrophysiological features distinct from non-dopaminergic neurons
The most defining feature of a neuron is its ability to fire action potentials in response to neurotransmitters from other neurons. In this regard, we exploited the possibility of identifying live DAn to analyze their capability to fire action potentials through studying calcium fluxes. The TH-mOrange iPSC line was differentiated towards floor plate derivatives and the resulting neuronal cultures were incubated with the calcium sensor Fluo-4 AM and imaged for periods of 30 minutes. Single calcium traces were dichotomized depending on whether they were recorded from mOrange+ or mOrange− cells (Fig. 3A,B). Both fluorescent and non-fluorescent neurons showed sharp spontaneous increases of Fluo-4 AM signal corresponding to the sudden influxes of calcium occurring during bursts (repeated action potentials) (blue arrowheads in Fig. 3B). While both groups of neurons showed similar firing patterns, we noted small but significant differences in the amplitude of the bursts. At day 35 of differentiation, the amplitude of the burst fired by mOrange− neurons was approximately 12% larger than those fired by mOrange+ neurons (2.954 ± 0.127 vs 3.296 ± 0.050; p = 0.030). This difference widened to 23% at day 50 of differentiation (2.494 ± 0.106 vs 3.082 +/− 0.090; p = 0.026) (Fig. 3C). These results underscore the importance of sampling a homogeneous and defined neuronal population in order to gain resolution when investigating disease-related phenotypes.
Flow cytometry-based isolation of homogenous populations of mOrange-labeled iPSC dopaminergic neurons
To obtain a homogenous population of mOrange-labeled iPSC-derived DAn, edited-iPSC DAn were isolated using fluorescence-activated cell sorting (FACS) at 27 days of differentiation. For this specific analysis, we utilized an alternative DAn differentiation protocol using dual-SMAD inhibition to obtain neural progenitor cells (NPCs) (Fig. S2A, B). With this protocol, NPCs can be expanded in the presence of fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF), cryopreserved, and rapidly differentiated into DAn13,18,19. Indeed, when we differentiated the TH-mOrange reporter line using this protocol, mOrange+ DAn could be visualized after only seven days of mitogen withdrawal. After 27 days of differentiation, cells were mechanically disaggregated, FACS-sorted and subsequently re-seeded on Matrigel-coated plates (Fig. 4A,B). Newly extended neurites were readily visible one day after sorting and the neuronal network continued gaining complexity over the following days (Fig. 4C,D), therefore that mOrange+ DAn are amenable to FACS-sorting procedures while remaining viable and maintaining their DA identity. Quantification analysis after immunostaining with an antibody to TH confirmed robust DAn purification from the mOrange+ sorted cells (>95% of cells were TH/mOrange-double positive). In addition, mOrange-negative sorted cells showed similar levels of mOrange+/TH+ neurons as the unsorted cells (60.8% vs. 67.5%), suggesting that the mOrange− population contains mitotically active undifferentiated progenitors or neurons that have not yet switched on TH expression (Fig. 4E). These results were confirmed by FACS analysis of the sorted neurons seven days after the initial isolation (Fig. 4B).
Collectively, these results demonstrate that post-mitotic fluorescent DAn can be purified from heterogeneous cultures and maintained in culture after sorting.
Genetic reporters are extremely useful tools to study signaling and regulatory networks, and offer a potentially powerful approach to identify and specifically isolate a cell type of interest from mixed cell populations. They also allow live real-time tracking, which provides a more in-depth approach to the study cellular dynamics and fate, for example, during the development of cell therapy applications.
Here, we used CRISPR/Cas9-based gene editing to generate an iPSC reporter line carrying a copy of mOrange under control of the endogenous TH promoter. The mOrange fluorescent construct was preceded by a self-excisable 2A peptide sequence and was fused to the last exon of the endogenous TH gene. The engineered reporter system was shown to work successfully using two different DAn differentiation protocols. First, using a differentiation protocol for floor plate progenitors6, we demonstrated the colocalization of the reporter protein in A9 DAn, which are the most vulnerable cells during PD pathogenesis. Secondly, fluorescent DAn were obtained after differentiating TH-mOrange hiPSCs to NPCs using dual SMAD inihibtion18. Since earlier attempts to visualize living dopaminergic cells were unsuccessful16, we believe the success of our strategy is based on the exceptional brightness of the mOrange protein.
Our ability to identify live dopaminergic neurons allowed us to quantify their electrophysiological activity, an important dynamic phenotype. By calcium imaging, we could distinguish very subtle differences in firing patterns between mOrange+ and mOrange− neurons. Specifically, we observed that mOrange− neurons exhibited bursts of higher amplitude, which directly corresponds to a higher overall activity given the correlation between the fluorescence amplitude ∆F/F0 and the number of elicited action potentials20. Accordingly, the ability to sample a specific neuronal subtype should help to minimize the variability associated with the differentiation procedure. This is crucial when probing subtle and cumulative phenotypes typical of late onset disease such as PD.
Our novel genetic TH reporter system enabled us to successfully isolate and purifiy mOrange+ DAn and later resume in vitro culture while preserving their dopaminergic identity. Post-sorted DAn successfully attached to plates and extended new neurites in a manner similar to that observed when generating primary neuronal cultures from fetal brain. The discordance in TH+ neuron number estimation using cytometry or immunofluorescence is likely due to the reduced sensitivity of the former, and the absolute expression of the TH gene would allow for the observation of those neurons with the highest TH expression. However, a counterweight to this limitation is the standardization of the sampled (or isolated) neurons, since they most likely represent a defined maturation stage.
In conclusion, we here developed an efficient method for generating TH reporter iPSCs that can be differentiated and sorted to obtain pure dopaminergic neuronal populations without the commonly observed heterogeneity of iPSC-derived dopaminergic cultures. We believe that our novel TH reporter tool will facilitate future research on the processes associated with specific DAn biology and disease.
The previously generated SP_11 iPSC line (from a healthy control subject) was used, and cells were cultured as described2. Briefly, hiPSC were cultured on Matrigel-coated plates (Corning, NY) and maintained in human embryonic stem cell medium consisting of KnockOut (KO)-DMEM supplemented with 20% KO-Serum Replacement (Gibco/Invitrogen, Carlsbad, CA), 2 mM ultraglutamine, non-essential amino acids and 1% penicillin/streptomycin (all from Lonza), 50 µM 2-mercaptoethanol (Gibco/Invitrogen) and 10 ng/ml bFGF (PeproTech, Rocky Hill, NJ), at 37 °C, 5% CO2. The medium was preconditioned overnight by irradiated mouse embryonic fibroblasts.
Generation of CRISPR/Cas9 plasmids and donor template for homology-directed repair
The CRISPR/Cas9 plasmid pSpCas9(BB)-2A-GFP (PX458) was a gift from Dr. Feng Zhang (Broad Institute, MIT; Addgene plasmid #12345)21. The original pCbh promoter was exchanged for the full-length pCAGGS promoter to achieve higher expression levels in hiPSCs. Custom guide RNAs were cloned into the BbsI sites as annealed oligonucleotides. The donor template for HDR was generated using standard molecular cloning procedures. Briefly, for TH donor template, homology arms were amplified from genomic DNA and verified by Sanger sequencing. Resulting sequences matched those of the reference genome GRCh38. The homology arms were inserted into the KpnI-ApaI (5′HA) and SpeI-XbaI (3′HA) sites of pBS-SK (−). The sequence coding for the P2A peptide was added to mOrange with the primers used to amplify the gene and the PCR product was inserted into the ApaI-XhoI sites of the pBS-5′HA-3′HA plasmid. Finally, pRex1-Neo-SV40 was inserted between the XhoI and SpeI of the plasmid.
Gene edition in iPSC
To generate the TH-mOrange hiPSC reporter cell line, cells were transfected with the HDR template and a Cas9- and gRNA-encoding plasmid; the latter overlapping the TH gene stop codon. In total, 800,000 iPSCs were seeded in 10 cm plates the day before transfection. iPSCs were co-transfected with 6 µg of CRISPR/Cas9 plasmid and 9 µg HDR template using FuGENE HD (Promega) at a 1:3 DNA to reagent ratio. Cells were plated in selection medium containing 50 µg/mL G418 (Melford Laboratories Ltd., Ipswich, UK) and maintained for 2 weeks until resistant colonies could be screened. At that time, one-half of each resistant colony was manually picked and site-specific integration was verified by PCR.
To excise the selection cassette, edited iPSCs were transfected with a CRE recombinase-expressing plasmid, gifted from Dr. Michel Sadelain (Sloan Kettering Institute; Addgene plasmid #27546)22. At 48 hours post-transfection, cells were dissociated and seeded at clonal density on a feeder layer of irradiated human fibroblasts. When colonies attained a certain size, they were picked and subcultured in independent Matrigel-coated wells. Cells were sampled and checked for cassette excision by PCR and Sanger sequencing. Those clones in which the cassette was excised were expanded, cryopreserved and karyotyped.
Generation of iPSC-derived ventral midbrain dopaminergic neurons
For the derivation of vmDAn, we used a previously published protocol6 with minor modifications. Briefly, iPSCs were maintained in mTeSR-1 medium (StemCell Technologies, Vancouver, Canada) until they reached 80% confluence and were then cultured in serum replacement medium (day 0) (KO-DMEM, 15% KO serum, 1% non-essential amino acids, 1% GlutaMax and 1% penicillin/streptomycin) for an additional 5 days. After that, iPSCs were grown in neurobasal medium 1% N2 (17502-048; Gibco/Invitrogen), 2% B27 (17054-044; Gibco/Invitrogen) (N2B27) without vitamin A and with 1% penicillin/streptomycin. At day twelve, N2 was removed from the medium until the end of the differentiation. The medium was supplemented with SB-431542 (10 mM; day 0–day 5; Sigma-Aldrich, St Louis, MI), LDN193189 (100 nM; day 0–day 12; Miltenyi Biotec Inc., San Diego, CA), CHIR99021 (3 mM; day 3–day 25; Miltenyi), purmorphamine (2 mM; day 1–day 5; Stemgent, Cambridge, MA), Smoothened agonist (1 mM; day 1–day 5; Tocris, Bristol, UK), brain-derived neurotropic factor (BDNF) (20 ng/ml; from day 12; Miltenyi), glial cell-derived neurotropic factor (GDNF) (20 ng/ml; from day 12; Miltenyi), DAPT (10 mM; from day 12; Tocris), db-cAMP (500 mM; from day 12; Sigma-Aldrich), TGFβ3 (1 ng/ml; from day 12; Miltenyi) and ascorbic acid (AA, 200 mM; from day 12; Sigma-Aldrich). On day 20, cells were dissociated using Accutase (Merck, Kenilworth, NJ), re-plated at 0.75 × 105 cells per cm2 on dishes pre-coated with polyornithine (15 μg/ml), laminin (1 μg/ml) and fibronectin (2 μg/ml), and cultured in neurobasal medium with 2% B27 without vitamin A and with 1% penicillin/streptomycin and trophic factors (GDNF, BDNF, TGFb3, AA, db-cAMP and DAPT) until analysis. Quantification of neurons (at day 35, 50 and 80) was assessed by confocal microscopy using anti-FOXA2, anti-MAP2, anti-TH and anti-GIRK2 antibodies.
Generation of human neural progenitor cells
For the generation of NPCs, we followed a previously published protocol19. Briefly, hiPSC colonies were gently disaggregated from the culture plate and plated for 6 hours in non-adherent conditions in DMEM/F12 (Gibco/Invitrogen), 2% B27, 1% N2, 10 μM Y-27632 (Miltenyl-Biotech), 100 nM LDN-193189 (120-10 C; PeproTech), 10 μM SB431542 (S4317-5MG; Sigma-Aldrich) and 2 ng/ml bFGF. Cells were then plated for 10 days on Matrigel-coated dishes in this medium before being detached with accutase and re-plated on Matrigel-coated dishes and cultured in neural induction medium: 1:1 DMEM/F12:neurobasal medium supplemented with 2% B27, 1% N2, 1% ultraglutamine, 10 ng/ml Epidermal Growth Factor (EGF; AF-100-15 Peprotech) and 10 ng/ml bFGF. Culturing cells in this neural induction medium generates homogenous cultures of NSCs (>95% of the cells).
NPC differentiation to dopaminergic neurons
NSCs were grown at high confluence (70%) for 7 days on Matrigel-coated dishes in N2B27 medium supplemented with 200 ng/ml Sonic Hedgehog and 100 ng/ml FGF8 (100-25; PreproTech). This first culture step was required to pattern NPCs as DAn progenitors. For terminal differentiation, DAn progenitors were plated on polyornitine/laminin-coated dishes in N2B27 medium supplemented with 20 ng/ml BDNF (450-02, PeproTech), 20 ng/ml GDNF (450-10, PeproTech), 0.5 mM db-cAMP (A6885-25MG, Sigma-Aldrich) and 5 µM DAPT (565770; Calbiochem, San Diego, CA) for the indicated time points.
Cells were fixed with 4% paraformaldehyde in PBS at room temperature for 15 min and permeabilized for 15 min in 0.3% Triton X-100 in TBS. Cells were then blocked in Triton X-100 with 3% donkey serum for 2 h. The following antibodies were used: goat anti-Nanog (R&D Systems, Minneapolis, MI; AF1997; 1:50), mouse IgM anti-Tra-1-81 (Merck-Millipore; MAB4381; 1:200), mouse anti-OCT4 (Santa Cruz Biotechnology, Santa Cruz, CA; sc-5279; 1:30), rat IgM anti-SSEA-3 (Developmental Studies Hybridoma Bank [DSHB] Iowa City, IA; MC-631; 1:10), mouse-SOX2 (R&D Systems; MB2018; 1:50), mouse anti-SSEA-4 (DSHB; MC-813-70; 1:100), mouse anti-NESTIN (Santa Cruz; sc-23927; 1:300action), rabbit anti-LMX1A (Millipore; ab10533; 1:1000), goat anti-EN1 (Santa Cruz; sc-46101; 1:200), mouse anti-TUJ1 (BioLegend, San Diego, CA; 801202; 1:500), chicken anti-MAP2ab (Abcam ab5392; 1:1000) goat anti-FOXA2 (R&D Systems; AF2400; 1:50), rabbit anti-TH (Santa Cruz Biotechnology; sc-14007; 1:500), sheep anti-TH (Pel-Freez Biologicals, Rogers, AR; P60101-0 1:500), rabbit anti-mRFP (Abcam, Cambridge, NA; ab34771; 1:400), rabbit anti-GIRK2 (Sigma-Aldrich; P8122; 1:40). Secondary antibodies used were the Alexa Fluor Series from Jackson ImmunoResearch Europe (Newmarket, UK) (all 1:500). Images were taken using a Leica SP5 confocal microscope. To visualize nuclei, slides were stained with 0.5 µg/ml DAPI (4′,6-diamidino-2-phenylindole) and then mounted with polyvinyl alcohol with DABCO® (SIGMA).
At days 35 and 50 of differentiation vmDAn were incubated with the calcium indicator Fluo-4 AM (Invitrogen) for 30 minutes, with gentle shaking at room temperature. Spontaneous neuronal activity was monitored for 20 minutes with a CMOS fluorescence camera (Hamamatsu Orca Flash v4; Hamamatsu Photonics, Tokyo, Japan) at a rate of 20 images/s and a spatial resolution of 2.3 µm/pixel, which allowed for the identification of single neuronal bodies. Data acquisition was controlled through the software Hokawo 2.10 (Hamamatsu). Data analysis was carried out with the software NETCAL23, which registers the variation of the fluorescence signal for each neuron as a function of time, and is directly related with calcium uptake and release. The fluorescence signal for each neuron was expressed as ΔF/F0 (%) = 100·(F − F0)/F0, where F0 is the average fluorescence value of the neuron at rest.
Neuronal fluorescence traces were next analyzed with NETCAL to infer the timing of neuronal activations. The Schmitt trigger method24 was used for inference. This method scans the fluorescence traces for events that first pass a high threshold and then remain elevated above a second lower threshold for at least a certain minimum duration. In our analysis, we used +3 standard deviations (SD) of the mean of the baseline noise as the high threshold, +2 SD as the low threshold, and 200 ms as the minimum event length.
The series of detected activity events were further contrasted with the fluorescence signal to determine the amplitude A of each activity event. The distribution of amplitude values for mOrange+ and mOrange− was then computed and the mean and SD values of the distributions finally evaluated.
Differences among groups were evaluated by one-way analysis of variance, and comparisons between two groups by Student’s t-test, using Prism (Mac OS X). Error bars represent mean ± SEM. A p-value less than 0.05 was considered significant.
All methods were performed in accordance with the relevant guidelines and regulations. The subject from whom iPSC were obtained, gave written informed consent prior to their participation in the study. The Commission on Guarantees for Donation and Use of Human Tissues and Cells of the Instituto de Salud Carlos III (ISCIII) and the local ethics committee at the Hospital Clínic de Barcelona approved the study, in full compliance with Spanish and European laws and regulations.
Sulzer, D. & Surmeier, D. J. Neuronal vulnerability, pathogenesis, and Parkinson’s disease. Mov. Disord. 28, 41–50 (2013).
Sánchez-Danés, A. et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol. Med. 4, 380–95 (2012).
Nguyen, H. N. et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267–80 (2011).
Arenas, E., Denham, M. & Villaescusa, J. C. How to make a midbrain dopaminergic neuron. Development 142, 1918–36 (2015).
Kirkeby, A. et al. Generation of Regionally Specified Neural Progenitors and Functional Neurons from Human Embryonic Stem Cells under Defined Conditions. Cell Rep. 1, 703–714 (2012).
Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480, 547–51 (2011).
Cooper, O. et al. Differentiation of human ES and Parkinson’s disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci. 45, 258–266 (2010).
Sánchez-Danés, A. et al. Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Hum. Gene Ther. 23, 56–69 (2012).
Kajiwara, M. et al. Donor-dependent variations in hepatic differentiation from human- induced pluripotent stem cells. Proc. Natl. Acad. Sci. 109, 12538–12543 (2012).
Kyttälä, A. et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports 6, 200–212 (2016).
Lee, C.-T. et al. Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation. Cell Rep. 10, 616–32 (2015).
Haavik, J. & Toska, K. Tyrosine hydroxylase and Parkinson’s disease. Mol. Neurobiol. 16, 285–309 (1998).
Bardy, C. et al. Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology. Mol. Psychiatry 21, 1573–1588 (2016).
Marchetto, M. C. N. et al. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649–57 (2008).
Cui, J. et al. Quantification of dopaminergic neuron differentiation and neurotoxicity via a genetic reporter. Sci. Rep. 6, 25181 (2016).
Xia, N. et al. A Knockin Reporter Allows Purification and Characterization of mDA Neurons from Heterogeneous Populations. Cell Reports 18, 2533–2546 (2017).
Shaner, N. C. et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22, 1567–1572 (2004).
Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275–280 (2009).
Borgs, L. et al. Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects. Sci. Rep. 6, 33377 (2016).
Weir, K., Blanquie, O., Kilb, W., Luhmann, H. J. & Sinning, A. Comparison of spike parameters from optically identified GABAergic and glutamatergic neurons in sparse cortical cultures. Front. Cell. Neurosci. 8, 460 (2015).
Ran et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 8, 2281–2308 (2013).
Papapetrou, E. P. et al. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat. Biotechnol. 29, 73–78 (2011).
Yamamoto, H. et al. Impact of modular organization on dynamical richness in cortical networks. Sci. Adv. 4, eaau4914 (2018).
Lee, D., Huang, T.-H., De La Cruz, A., Callejas, A. & Lois, C. Methods to investigate the structure and connectivity of the nervous system. Fly 11(3), 224–238 (2017).
The authors thank Yvonne Richaud-Patin for her participation in the generation of the original iPSC line and for technical support, and Marta Cañizares for performing immunofluorescence staining. We are grateful to the Advanced Fluorescence Microscopy Unit of the Institute of Biomedicine of the University of Barcelona (especially to Elena Rebollo Arredondo). Research from the authors’ laboratories is supported by the European Research Council-ERC (2012-StG-311736-PD-HUMMODEL), the European Union’s Horizon 2020 Program (MESOBRAIN project; grant agreement No 713140), the Spanish Ministry of Economy and Competitiveness-MINECO (SAF2015-69706-R; BFU2017-83066-P; and BFU2016-80870-P), Instituto de Salud Carlos III-ISCIII/FEDER (Red de Terapia Celular - TerCel RD16/0011/0003 and RD16/0011/0024; PIE12/00061), AGAUR (2017-SGR-899 and 2017-SGR-1061), and CERCA Program/Generalitat de Catalunya. C.C. is supported by the PD-HUMMODEL European Research Council (ERC)- Ideas PhD fellowship. G.C. is partially supported by pre-doctoral fellowship from Spanish Economy and Competitiveness-MINECO (BES-2014-069603). The authors declare that they have no competing interests.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Calatayud, C., Carola, G., Fernández-Carasa, I. et al. CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons. Sci Rep 9, 6811 (2019). https://doi.org/10.1038/s41598-019-43080-2
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
Molecular Brain (2021)
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
npj Parkinson's Disease (2021)
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Cellular and Molecular Life Sciences (2021)
Profiling parvalbumin interneurons using iPSC: challenges and perspectives for Autism Spectrum Disorder (ASD)
Molecular Autism (2020)